Full-Time

Technical Senior Project Manager

Sia Partners

Sia Partners

1,001-5,000 employees

Global management consulting powered by data

No salary listed

Paris, France

Remote

Category
Business & Strategy (1)
Required Skills
Risk Management
Requirements
  • 8+ years of experience in the biopharmaceutical industry with a minimum of 5 years of project management experience
  • BS, MS, or PhD in a scientific or engineering discipline (e.g., Chemistry, Biochemistry, Chemical or Biomedical Engineering, Pharmaceutical Sciences)
  • Experience working with contract development and manufacturing organizations to support outsourced development and manufacturing activities, including oversight of deliverables and timelines
  • Ability to engage in technical and scientific discussions
  • Strong communication and interpersonal skills, with the ability to influence, collaborate, and build alignment across diverse technical and leadership teams
  • Proficiency in Planisware and principles to plan, manage, and track multiple parallel projects in a complex, matrixed environment
  • Fluent and articulate communication in English (written and spoken)
  • Excellent written and oral communication, presentation, problem solving, and negotiation skills with an emphasis on building consensus
  • Ability to work independently and in collaboration with others
  • Flexibility and ability to deal with ambiguity, and sense of personal ownership of deliverables and results
  • Works well with teams, often comprised of multiple disciplines
Responsibilities
  • Provide consulting services for Sia/LBG’s clients including, but not limited to:
  • Routinely provide strategic oversight to maintain alignment of project milestones to day-to-day activities.
  • Responsible for content, quality, and distribution of project management deliverables (reports, dashboards, etc.) and routine updates (schedule, budget, risk), typically as the final reviewer.
  • Establish strong working relationships with leadership and project functional teams across all levels.
  • Serve as project spokesperson and facilitate communications with all internal and external stakeholders (meetings, reports, etc.).
  • Work with cross-functional teams (CMC, Med. Affairs/Clinical, Nonclinical, Quality, Regulatory, Finance, Legal, Contracts Management, etc.) to drive project activities against scheduled timelines, approved scope, and approved budget.
  • Manage project financials including vendor invoice review/approval, budget development, actuals tracking, maintenance of time-phased financial forecast, preparation of project financial reports for internal and external stakeholders.
  • Proactively manage strategic risks and issues, providing expertise in the identification and implementation of risk mitigation activities.
  • Demonstrate and foster excellent teamwork, with the ability to navigate within multidisciplinary teams.
  • Balance project demands to align/realign Budget, Quality, Timeline, and Scope, as needed.
  • Lead product development meetings, and ensure all Project Leaders, and/or subteam leaders, have all the information and support needed to implement the project.
  • Focus on customer service, with agility and clear communication.
  • Adhere to Sia/LBG quality standards regarding client deliverables
Desired Qualifications
  • Comprehensive understanding of CMC, including: Small molecule, biologics, or vaccine formulation, process development, analytical development, and GMP manufacturing across both early and late-stage development
  • Formal project management training or certification (e.g., PMP)
  • Strong understanding of product development lifecycle and pharmaceutical manufacturing operations
  • Strong understanding of cGXP guidelines and regulatory requirements

Sia Partners is a global management consulting group that blends digital capabilities, data analytics, creative thinking, and a sense of responsibility to help clients solve problems and seize opportunities in a changing business landscape. Their work combines strategic advisory with implementation support, using data-driven insights and digital tools to diagnose issues, design solutions, and drive transformation across functions and industries. Sia differentiates itself through its data-forward, technology-enabled approach paired with creative problem-solving and a commitment to responsible practices, aiming to deliver practical, sustainable outcomes for organizations worldwide. The company's goal is to help clients navigate disruption, transform operations and strategy, and achieve measurable, responsible growth.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$12.7M

Headquarters

Paris, France

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Blackstone's €250m investment accelerates US expansion to 2,000 consultants.
  • Kaiser Associates adds 65 consultants boosting North American private equity advisory.
  • Precedence acquisition doubles Dutch headcount in data and AI leadership.

What critics are saying

  • Key partners Ali Cumber and Paul Mumma depart post-Kaiser integration.
  • Blackstone pressures trigger cost overruns hitting 2027 US targets.
  • LEK Consulting poaches 20-30% of Sia's PE advisory revenue.

What makes Sia Partners unique

  • Sia integrates AI agents into strategy consulting via 800+ Agent Store offerings.
  • Acquired Kaiser Associates launches global PE and M&A business line.
  • Acquisitions like The Upside enhance UK brand and innovation capabilities.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Sia Partners who can refer or advise you

Benefits

Professional Development Budget

Company News

The Associated Press
Jan 27th, 2026
Sia acquires Kaiser Associates to launch global corporate strategy and M&A business line

Sia, a global management consulting group, has acquired Kaiser Associates, a US-based strategy consulting firm, to launch a dedicated Corporate Strategy, Private Equity and M&A business line spanning the US, UK, France, Middle East and Australia. Founded in 1981, Kaiser Associates brings 65 consultants and operates from Washington, D.C., New York and London. The firm specialises in go-to-market strategy, growth assessments and market landscaping for Fortune 500 executives and private equity funds. Kaiser Associates' leadership team, including Ali Cumber, Paul Mumma and Jon Meyerholz, will join Sia as partners, with Meyerholz heading the new business line as managing partner. The acquisition expands Sia's North American presence and strengthens its position in private equity advisory.

Business Wire
Jul 4th, 2025
Sia Expands in the Netherlands with the Acquisition of Precedence

Sia continues its strategic expansion with the acquisition of Precedence, a consulting player.

Consultancy.uk
May 9th, 2025
Sia Acquires The Upside for Expansion

Sia has acquired The Upside, enhancing its brand, innovation, and cultural strategy capabilities in the UK. The Upside, founded in 2013, generated £6.2 million in 2024 revenues. This acquisition follows Sia's €250 million minority investment from Blackstone, supporting its European expansion. Niku Banaie, CEO of The Upside, will lead Sia's UK brand, innovation, and culture team. The Upside will adopt Sia's branding as part of the transition.

Business Plus
Dec 17th, 2024
Sia Partners receives €250m investment from Blackstone

Dublin-based management and AI consulting firm Sia Partners has received investment of up to €250m from Blackstone, one of the world's largest alternative

Finyear
Dec 16th, 2024
Sia Partners receives €250m from Blackstone

Sia Partners has opened its capital to Blackstone, the world's largest alternative asset manager, through a €250 million minority investment. Despite this, founder and CEO Matthieu Courtecuisse retains a majority stake. This marks the first time Sia Partners has sought a financial partner since its founding in 1999. The firm, with nearly €500 million in revenue, aims to accelerate growth, especially in the U.S. and other countries where it operates.